Authors : Willard FS, Douros JD, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, Cardona GR, Urva S, Emmerson PJ, Rosenkilde MM, Campbell JE, Sloop KW Source : Studies of the dual GIP and GLP-1 receptor agonist tirzepatide reveal occupancy favoring the GIP receptor and biased cAMP signaling at the GLP-1 receptor
The GLP-1 receptor agonists, exenatide and liraglutide, mimic the action of endogenous GLP-1
Yes, tirzepatide can be used safely with hyperthyroidism when thyroid function is monitored regularly and your antithyroid medications are optimized
Although genome similarities are important, they might not fully represent the scientific understanding of the phenomenon or discovery
Have a phone charger so you can call for help if necessary
LY3372689 is a small-molecule inhibitor of O-GlcNAcase, which promotes tau glycosylation and prevents tau aggregation [58]